Standaard Boekhandel gebruikt cookies en gelijkaardige technologieën om de website goed te laten werken en je een betere surfervaring te bezorgen.
Hieronder kan je kiezen welke cookies je wilt inschakelen:
Technische en functionele cookies
Deze cookies zijn essentieel om de website goed te laten functioneren, en laten je toe om bijvoorbeeld in te loggen. Je kan deze cookies niet uitschakelen.
Analytische cookies
Deze cookies verzamelen anonieme informatie over het gebruik van onze website. Op die manier kunnen we de website beter afstemmen op de behoeften van de gebruikers.
Marketingcookies
Deze cookies delen je gedrag op onze website met externe partijen, zodat je op externe platformen relevantere advertenties van Standaard Boekhandel te zien krijgt.
Je kan maximaal 250 producten tegelijk aan je winkelmandje toevoegen. Verwijdere enkele producten uit je winkelmandje, of splits je bestelling op in meerdere bestellingen.
The research presented in this book is comprised of two parts. Part A is related to research focused on protein glycation which is one of the major causes of diabetic complications. standard bio-assay was established to screen natural and synthetic compounds to discover new lead molecules with high potency and low toxic effects. More than 1000 compounds were investigated and detailed studies were performed. As a result several promising inhibitors of protein glycation belonging to different classes were identified and their cytotoxic effects were determined for their safer use. Part B of this book is related to receptor-based studies on type-2 diabetes mellitus. In this case we used glucagon and GLP-1 receptors.New mutants of these receptors were prepared by site-directed mutagenesis. These new mutants along with parent DNA were expressed in Human Embryonic Kidney cells which were tested for cAMP (secondary messenger) production. cAMP is responsible for the release of glucose from liver in case of glucagon receptor while in case of GLP-1 receptor cAMP is responsible for the release of insulin. Synthetic compounds were also tested against both receptors for cAMP production.